RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Clinical trial NCT04514653 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04514653
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2026-08-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.